Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Returned to the company SVP, Products Business returned 8,655 shares (to the company)
  2. 4 Returned to the company SVP, Bioservices returned 5,771 shares (to the company)
  3. 4 Returned to the company EVP, Chief Financial Officer returned 46,155 shares (to the company)
  4. 4 Shares withheld for taxes SVP, R&D, CMO gave up 3,543 shares (to pay taxes)
  5. 4 Open-market sale Director sold 21,984 shares at an average $11.97 ($263,077)
  6. 4 Shares withheld for taxes SVP, Bioservices gave up 610 shares (to pay taxes)
  7. 4 Open-market sale Director sold 17,801 shares at $10.54 ($187,623)
  8. 4 Open-market sale Director sold 8,552 shares at $10.00 ($85,520)
  9. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,995 shares (to pay taxes)
  10. 4 Open-market sale EVP, Quality & Ethics, and CPL sold 30,608 shares at $10.00 ($306,080)
  11. 4 Planned sale Director sold 7,086 shares at $8.87 ($62,853)
  12. 4 Open-market sale Director sold 7,844 shares at $8.65 ($67,831)
  13. 4 Shares withheld for taxes SVP, Bioservices gave up 4,263 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP, Bioservices gave up 1,167 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 1,249 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP, Products Business gave up 464 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,733 shares (to pay taxes)
  18. 4 Planned sale Director sold 7,844 shares at $6.30 ($49,417)
  19. 4 Open-market buy President and CEO bought 60,000 shares at $5.83 ($349,800)
  20. 4 Grant or award Director acquired 34,403 shares (grant or award)

Page 3 of 49 · 970 filings